OBJECTIVE: Fecal microbiota transplantation (FMT) has been suggested as a new treatment to manage Clostridium difficile infection (CDI). With use of a mathematical model of C. difficile within an intensive care unit (ICU), we examined the potential impact of routine FMT. DESIGN, SETTING, AND PATIENTS: A mathematical model of C. difficile transmission, supplemented with prospective cohort, surveillance, and billing data from hospitals in the southeastern United States. METHODS: Cohort, surveillance, and billing data as well as data from the literature were used to construct a compartmental model of CDI within an ICU. Patients were defined as being in 1 of 6 potential health states: uncolonized and at low risk; uncolonized and at high risk; colonized and at low risk; colonized and at high risk; having CDI; or treated with FMT. RESULTS: The use of FMT to treat patients after CDI was associated with a statistically significant reduction in recurrence but not with a reduction in incident cases. Treatment after administration of high-risk medications, such as antibiotics, did not result in a decrease in recurrence but did result in a statistically significant difference in incident cases across treatment groups, although whether this difference was clinically relevant was questionable. CONCLUSIONS: Our study is a novel mathematical model that examines the effect of FMT on the prevention of recurrent and incident CDI. The routine use of FMT represents a promising approach to reduce complex recurrent cases, but a reduction in CDI incidence will require the use of other methods to prevent transmission.
OBJECTIVE: Fecal microbiota transplantation (FMT) has been suggested as a new treatment to manage Clostridium difficile infection (CDI). With use of a mathematical model of C. difficile within an intensive care unit (ICU), we examined the potential impact of routine FMT. DESIGN, SETTING, AND PATIENTS: A mathematical model of C. difficile transmission, supplemented with prospective cohort, surveillance, and billing data from hospitals in the southeastern United States. METHODS: Cohort, surveillance, and billing data as well as data from the literature were used to construct a compartmental model of CDI within an ICU. Patients were defined as being in 1 of 6 potential health states: uncolonized and at low risk; uncolonized and at high risk; colonized and at low risk; colonized and at high risk; having CDI; or treated with FMT. RESULTS: The use of FMT to treat patients after CDI was associated with a statistically significant reduction in recurrence but not with a reduction in incident cases. Treatment after administration of high-risk medications, such as antibiotics, did not result in a decrease in recurrence but did result in a statistically significant difference in incident cases across treatment groups, although whether this difference was clinically relevant was questionable. CONCLUSIONS: Our study is a novel mathematical model that examines the effect of FMT on the prevention of recurrent and incident CDI. The routine use of FMT represents a promising approach to reduce complex recurrent cases, but a reduction in CDI incidence will require the use of other methods to prevent transmission.
Authors: Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney Journal: Clin Infect Dis Date: 2007-03-01 Impact factor: 9.079
Authors: Umair Jabbar; Julie Leischner; Douglas Kasper; Robert Gerber; Susan P Sambol; Jorge P Parada; Stuart Johnson; Dale N Gerding Journal: Infect Control Hosp Epidemiol Date: 2010-06 Impact factor: 3.254
Authors: Deverick J Anderson; Becky A Miller; Luke F Chen; Linda H Adcock; Evelyn Cook; A Lynn Cromer; Susan Louis; Paul A Thacker; Daniel J Sexton Journal: Infect Control Hosp Epidemiol Date: 2011-04 Impact factor: 3.254
Authors: Dan R Thompson; D Kirk Hamilton; Charles D Cadenhead; Sandra M Swoboda; Stephanie M Schwindel; Diana C Anderson; Elizabeth V Schmitz; Arthur C St Andre; Donald C Axon; James W Harrell; Maurene A Harvey; April Howard; David C Kaufman; Cheryl Petersen Journal: Crit Care Med Date: 2012-05 Impact factor: 7.598
Authors: J-C Lagier; M Delord; M Million; P Parola; A Stein; P Brouqui; D Raoult Journal: Eur J Clin Microbiol Infect Dis Date: 2015-05-07 Impact factor: 3.267